Publisher's note: This series was paid for by National Minority Quality Forum. The views expressed are the authors' own. The National Minority Quality Forum (NMQF) has commissioned this analysis ...
When Medicare coverage for a drug, device, or other medical technology is conditioned on additional evidence development, several important policy questions arise: What will be the utility of the ...
Medicare will speed nationwide payment decisions for as many as five promising new medical devices a year, a move that could get some products to patients earlier and spare companies from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results